Novavax reports promising early trial results of Covid-19 vaccine
The final stage Phase 3 trial of its vaccine, called NVX-CoV2373, is set to take place this fall
The final stage Phase 3 trial of its vaccine, called NVX-CoV2373, is set to take place this fall